Hiroya Tamai, Kei Ikeda, Toshiaki Miyamoto, Hiroaki Taguchi, Chang-Fu Kuo, Kichul Shin, Shintaro Hirata, Yutaka Okano, Shinji Sato, Hidekata Yasuoka, et al. Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial. The Lancet Rheumatology. 2023. 5. 4. e215-e224
Tamai Hiroya, Ikeda Kei, Miyamoto Toshiaki, Taguchi Hiroaki, Hirata Shintaro, Okano Yutaka, Sato Shinji, Yasuoka Hidekata, Kuwana Masataka, Ishii Tomonori, et al. Biologics in RA-2 関節リウマチ患者におけるメトトレキサート最大耐容量を減量したアダリムマブの有効性と安全性(MIRACLE) 無作為化非劣性比較試験(Efficacy and safety of adalimumab with reduced versus maximum tolerated methotrexate dose in patients with rheumatoid arthritis(MIRACLE): a randomized, non-inferiority trial). 日本リウマチ学会総会・学術集会プログラム・抄録集. 2023. 67回. 401-401